We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+25.86%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$8.86B
AUM Growth
+$2.24B
Cap. Flow
+$911M
Cap. Flow %
10.28%
Top 10 Hldgs %
59.7%
Holding
84
New
18
Increased
19
Reduced
9
Closed
12

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$95.7M
2
ENOV icon
Enovis
ENOV
+$83.4M
3
LILAK icon
Liberty Latin America Class C
LILAK
+$77M
4
NWL icon
Newell Brands
NWL
+$73.7M
5
EOSE icon
Eos Energy Enterprises
EOSE
+$70.5M

Top Sells

Rank Stock Value
1
TLN
Talen Energy Corp
TLN
+$326M
2
VST icon
Vistra
VST
+$276M
3
INDV icon
Indivior Pharmaceuticals
INDV
+$73.6M
4
ADPT icon
Adaptive Biotechnologies
ADPT
+$72.9M
5
COOP
Mr. Cooper
COOP
+$50.4M

Sector Composition

Rank Sector Weight
1 Healthcare 31.07%
2 Utilities 21%
3 Industrials 12.9%
4 Energy 5.78%
5 Financials 3.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TLN
1
Talen Energy Corp
TLN
$16.7B
$1.53B 17.29%
3,602,171
-903,131
-20% -$326M
SPY icon
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$823B
$933M 10.52%
+1,400,000
New +$897M
FTAI icon
3
FTAI Aviation
FTAI
$22.2B
$561M 6.33%
3,360,553
-33,527
-1% -$4.77M
TEVA icon
4
Teva Pharmaceuticals
TEVA
$41.2B
$498M 5.62%
24,650,000
-1,350,000
-5% -$23.7M
IWM icon
5
PUT
iShares Russell 2000 ETF
IWM
$83B
$484M 5.46%
+2,000,000
New +$459M
GLNG icon
6
Golar LNG
GLNG
$5.13B
$371M 4.19%
9,178,978
– –
ROIV icon
7
Roivant Sciences
ROIV
$26.2B
$303M 3.41%
20,000,000
-370,336
-2% -$4.58M
TAC icon
8
TransAlta
TAC
$3.93B
$218M 2.46%
15,948,451
– –
ARQT icon
9
Arcutis Biotherapeutics
ARQT
$3.18B
$203M 2.29%
10,749,457
– –
FLR icon
10
Fluor
FLR
$7.96B
$189M 2.14%
4,500,000
+500,000
+13% +$23M
MCY icon
11
Mercury Insurance
MCY
$6.07B
$174M 1.97%
2,054,504
– –
BGC icon
12
BGC Group
BGC
$4.89B
$170M 1.92%
18,000,000
+994,418
+6% +$9.96M
KNSA icon
13
Kiniksa Pharmaceuticals
KNSA
$5.93B
$155M 1.75%
4,000,000
+90,194
+2% +$2.93M
VTRS icon
14
Viatris
VTRS
$18.9B
$152M 1.72%
15,385,000
+3,385,000
+28% +$32.9M
QDEL icon
15
QuidelOrtho
QDEL
$838M
$137M 1.54%
4,637,738
– –
AMRX icon
16
Amneal Pharmaceuticals
AMRX
$5.79B
$123M 1.39%
12,334,941
+624,609
+5% +$5.61M
EOSE icon
17
Eos Energy Enterprises
EOSE
$1.51B
$117M 1.32%
+10,300,000
New +$70.5M
RNW icon
18
ReNew
RNW
$2.25B
$111M 1.25%
14,438,061
– –
IART icon
19
Integra LifeSciences
IART
$1.34B
$110M 1.24%
7,653,934
+300,000
+4% +$4.11M
SDGR icon
20
Schrodinger
SDGR
$1.36B
$106M 1.19%
5,268,817
+268,817
+5% +$5.4M
COLL icon
21
Collegium Pharmaceutical
COLL
$956M
$98.9M 1.12%
2,826,498
-331,245
-10% -$11.5M
ECVT icon
22
Ecovyst
ECVT
$1.14B
$91.1M 1.03%
10,400,000
+5,692,653
+121% +$50.2M
LBTYA icon
23
Liberty Global Class A
LBTYA
$3.6B
$88.8M 1%
7,750,367
+2,058,142
+36% +$22.6M
SSYS icon
24
Stratasys
SSYS
$774M
$87.4M 0.99%
7,803,097
– –
DK icon
25
Delek US
DK
$3.58B
$86.7M 0.98%
2,687,449
– –
1
2 3 4

Similar funds

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
BAMF
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $9.55B AUM 31.94% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return

Rubric Capital Management (New York)'s Q3 2025 Portfolio in Review

As of Q3 2025, Rubric Capital Management (New York) held 84 positions worth $8.86B, up 34% from $6.62B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Rubric Capital Management (New York) deployed $911M of net new capital in Q3 2025, opening 18 new positions and adding to 19 existing holdings. Its largest new stake was Baxter International: 3,774,889 shares worth $86M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Utilities and Industrials.

On the sell side, the largest reduction was Talen Energy Corp, an estimated $326M trimmed.

  • Rubric Capital Management (New York)'s largest Q3 2025 buy was Baxter International: 3,774,889 shares worth $86M.
  • Rubric Capital Management (New York) added most to Ecovyst in Q3 2025, an estimated $50.2M increase.
  • Rubric Capital Management (New York)'s biggest Q3 2025 reduction was Talen Energy Corp, cutting an estimated $326M.
  • Rubric Capital Management (New York) fully exited Vistra in Q3 2025, selling an estimated $276M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 60% of its $8.86B portfolio in Q3 2025.
  • Rubric Capital Management (New York) opened 18 new positions and closed 12 in Q3 2025.
  • Rubric Capital Management (New York)'s portfolio value rose 34% quarter-over-quarter to $8.86B.

Based on Rubric Capital Management (New York)'s 13F filing for Q3 2025, filed 14 Nov 2025.